My pleasure sir. Plus the current Phase 1 clinica
Post# of 72444
My pleasure sir.
Plus the current Phase 1 clinical trial with Kevetrin alone is jointly with both Dana-Farber and Beth Israel Deaconess, both members of the Harvard Cancer Center.
So if this new research result leads to a Phase 2 Clinical Trial at Beth Israel, that will be the second Kevetrin trial hosted there.

